The aim of this study is to investigate the effect disease activity on resting energy expenditure (REE), body composition, inflammatory markers, food intake and quality of life in subjects affected by Crohn's Disease (CD)
Malnutrition is a common sequel among patients affected by Crohn's disease (CD). The pathogenic mechanisms include poor dietary intake, increased resting energy expenditure (REE), nutrient malabsorption and loss. So far, few studies have been carried out in CD adult patients, assessing the effect of disease activity on both REE and body composition. Vaisman et al (2006) studied sixteen CD patients in remission (\> 3 mo) and showed no effect of REE on lower BMI, although in the presence of similar energy intake in according with previous studies (Al-Jaouni et al., 2000; Schneeweiss et al., 1999). While, Gong et al., 2015 found that patients with active disease had an increase in REE compared to patients in remission as already shown by Rigaud et al., 1993; Kushner and Schoeller, 1991. Overall, the effect of disease activity on REE is still uncertain and requires further investigation.
Study Type
OBSERVATIONAL
Enrollment
150
Measurement of resting energy expenditure
Federico II University Hospital
Napoli, Italy
RECRUITINGResting Energy Expenditure (REE) measured by Indirect Calorimetry (IC) in patients with Crohn's Disease
The measurement of REE by IC is a non-invasive method that measures oxygen consumption and carbon dioxide production and it is generally considered the gold standard in clinical practice.
Time frame: At baseline
Body composition assessment by bioelectrical impedence analysis (BIA)
Time frame: At baseline
Assessment of muscle function by hand-grip strength
Hand-grip strength will be performed by dynamometer
Time frame: At baseline
Food intake evaluation
Food intake will be assessed by filling 3 day food records
Time frame: At baseline
Inflammatory biomarkers
Serum concentration of high sensitive C-reactive protein (hs-RCP) will be determined by immunoturbidimetric assay while tumor necrosis factor - alpha (TNF-alpha) and Interleukin 6 (IL-6) will be assessed by ELISA.
Time frame: At baseline
Quality of Life (QoL)
Assessment of each patient's health and well-being using the short-form 36 (SF-36).
Time frame: At baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.